Home
 
Login  
About Hospital Safety Center  
Career Center  
Contact Us
 
Subscribe  
       Free Resources
Hospital Safety Insider
E-Newsletter

 
Mac's Safety Space  
        News & Analysis
Healthcare Safety Leader  
Environment of Care Leader  
Forms and Checklists Library  

 

 

     
This is an excerpt from a member-only article. To read the article in its entirety, please login or subscribe.

EPA offers definitions for new management of hazardous waste drugs

EMAIL THIS STORY | PRINT THIS STORY | SUBSCRIBE | ARCHIVES

October 1, 2019

by A.J. Plunkett (aplunkett@decisionhealth.com)

In February, the EPA published a long-awaited final rule on the management of hazardous waste pharmaceuticals that creates a new section, Subpart P, under the federal Resource Conservation and Recovery Act (RCRA).

The first deadline, the ban on sewering of all hazardous waste pharmaceuticals, was effective as of August 21 (see Ensure compliance with EPA rule: Ban all sewering of hazardous waste drugs). Other sections of the rule will go into effect as states adopt and revise their own EPA-approved RCRA programs.

In February, the EPA published a long-awaited final rule on the management of hazardous waste pharmaceuticals that creates a new section, Subpart P, under the federal Resource Conservation and Recovery Act (RCRA).



This is an excerpt from a member-only article. To read the article in its entirety, please login or subscribe.

Subscribe Now!
Sign up for our free e-newsletter
About Us | Terms of Use | Privacy Statement | Contact Us
Copyright © 2020. Hospital Safety Center.